AN2 Therapeutics, Inc. (ANTX) compared with its closest peers (WHWK, ORGO, NERV, RNA, IMUX). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Whitehawk Therapeutics Inc (WHWK) | $233.91M | -7.3 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Minerva Neurosciences, Inc. (NERV) | $230.14M | -0.1 |
| Avidity Biosciences, Inc. (RNA) | $226.39M | -14.5 |
| Immunic, Inc. (IMUX) | $225.00M | -0.9 |
| Keros Therapeutics, Inc. (KROS) | $219.29M | 8.8 |
| SIGA Technologies, Inc. (SIGA) | $218.76M | 10.8 |
| PepGen Inc. (PEPG) | $216.78M | -3.1 |
| Journey Medical Corporation (DERM) | $213.21M | -16.4 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $201.15M | -1.4 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
ANTX overview · ANTX earnings · ANTX financials · ANTX KPIs · ANTX investor relations · ANTX ownership · ANTX filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.